Invest in Kuwait and Healthcare Innovation with HANetf’s new launches

HANetf has launched two exciting new ETFs with tickers WELL and KUW8. Hector McNeil, co-CEO at HANetf came into the IG studio to discuss the new products.

The value of investments can fall as well as rise, and you may get back less than you invested. Past performance is no guarantee of future results

KUW8: KMEFIC FTSE Kuwait ETF

KUW8 is a FTSE Kuwait Equity UCITS ETF which tracks the FTSE Kuwait All Cap 15% Capped Index of securities on the main market of the Kuwait Stock Exchange. The fund aims to provide exposure to this emerging market, which has 'significant growth potential' says HANetf.

It is the only UCITS ETF that provides targeted exposure to Kuwait. KUW8 gives access to a 'diverse basket of Kuwaiti securities across market capitalisation bands and industry sectors', while avoiding 'concentration in larger stocks by capping constituent weights at 15% during a semi-annual rebalance'. The top holdings within the index include Kuwait Finance House, Ahli United Bank B.S.C., National Bank of Kuwait, Gulf Bank and Mobile Telecommunications Co KSC.

'From an investment perspective there’s a lot of good reasons that Kuwait is going to go places' says HANetf’s Hector McNeil. 'When we first looked at this we didn’t really think of Kuwait as the obvious place to have a market access product but there’s no other exchange traded funds (ETFs) in the world out there that gives that exposure'. He says 'Kuwait is massively overweight' among many active fund managers partly thanks to 'a big expenditure programme on infrastructure'.

WELL: HAN-GINS Indexx Healthcare Innovation ETF

According to HANetf, 'WELL tracks the Indexx Advanced Life Sciences & Smart Healthcare Thematic Index (Net Total Return), an index designed to measure the performance of performance of large, mid and small-capitalisation companies primarily listed on an exchange in Developed and Emerging Markets that are involved in the Advanced Life Sciences & Smart Healthcare sector.' The aim is to provide exposure to this emerging theme. Among the top holdings in the index are Edwards Lifesciences Corp, Boston Scientific Corp, Innumina Inc, Intuitive Surgical Inc and Medtronic Plc.

'Virtually, globally we are having an aging population and from that perspective, healthcare is becoming increasingly important' says McNeil. 'Generally in technology, there’s going to be more inventions in technology over the next ten years than there has been over the whole of history and I believe a lot of those inventions are going to be around healthcare as people are getting older'.

Form has failed to submit. Please contact IG directly.

  • I’d like to receive information from IG Group companies about trading ideas and their products and services via email.

Get my guide

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

●  Discover the benefits of investing your money

●  Learn about the different investment options available and how to get started

●  Understand how to build a diversified portfolio and manage your risk

Get your free beginner's guide to investing

Get your free beginner's guide to investing

●  Discover the benefits of investing your money

●  Learn about the different investment options available and how to get started

●  Understand how to build a diversified portfolio and manage your risk

Form has failed to submit. Please contact IG directly.

  • I’d like to receive information from IG Group companies about trading ideas and their products and services via email.

Get my guide

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.